A commentary on the promise of wholeexome sequencing in medical genetics, J Hum Genet, vol.59, pp.117-125, 2014. ,
What can exome sequencing do for you, J Med Genet, vol.48, pp.580-589, 2011. ,
Human genetics and clinical aspects of neurodevelopmental disorders, The Genetics of Neurodevelopmental Disorders, vol.2015, pp.289-317 ,
SoftSearch: integration of multiple sequence features to identify breakpoints of structural variations, PLoS One, vol.8, p.83356, 2013. ,
Detection of somatic copy number alterations in cancer using targeted exome capture sequencing, Neoplasia, vol.13, pp.1019-1040, 2011. ,
Copy number variation sequencing for comprehensive diagnosis of chromosome disease syndromes, J Mol Diagn, vol.16, pp.519-545, 2014. ,
Identification of copy number variants from exome sequence data, BMC Genomics, vol.15, p.661, 2014. ,
Exome sequencing: what clinicians need to know, Adv Genomics Genet, vol.4, pp.15-27, 2014. ,
Neurogenetics: five new things, Neurol Clin Pract, vol.1, pp.41-49, 2011. ,
Personalized cancer medicine-advances and socioeconomic challenges, Nat Rev Clin Oncol, vol.8, pp.735-776, 2011. ,
Practices and policies of clinical exome sequencing providers: analysis and implications, Am J Med Genet A, vol.161, pp.935-50, 2013. ,
Personalised medicine in the UK: challenges of implementation and impact on healthcare system, Genome Med, vol.6, p.28, 2014. ,
Clinical cancer research: the past, present and the future, Nat Rev Clin Oncol, vol.11, pp.663-672, 2014. ,
The promise and challenges of next-generation genome sequencing for clinical care, JAMA Intern Med, vol.174, pp.275-80, 2014. ,
Can I be sued for that? Liability risk and the disclosure of clinically significant genetic research findings, Genome Res, vol.24, pp.719-742, 2014. ,
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing, Genet Med, vol.15, pp.565-74, 2013. ,
Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing, Trends Biotechnol, vol.31, pp.439-480, 2013. ,
Paternalism and the ACMG recommendations on genomic incidental findings: patients seen but not heard, Genet Med, vol.15, pp.751-753, 2013. ,
Genomic medicine and incidental findings: balancing actionability and patient autonomy, Mayo Clin Proc, vol.89, pp.718-739, 2014. ,
Genetic incidental findings: autonomy regained, Genet Med, vol.15, pp.868-70, 2013. ,
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing, Genet Med, vol.17, pp.68-69, 2014. ,
Towards a European consensus for reporting incidental findings during clinical NGS testing, Eur J Hum Genet, vol.23, p.1601, 2015. ,
The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists, J Med Genet, vol.52, pp.431-438, 2015. ,
Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias, J Craniomaxillofac Surg, vol.39, pp.91-93, 2011. ,
Systematic reviews in the social sciences: a practical guide, 2006. ,
The qualitative content analysis process, J Adv Nurs, vol.62, pp.107-122, 2008. ,
Content analysis: method, applications, and issues, Health Care Women Int, vol.13, pp.313-334, 1992. ,
Nursing implications of personalized and precision medicine, Semin Oncol Nurs, vol.30, pp.130-136, 2014. ,
Implementing genomic medicine in pathology, Adv Anat Pathol, vol.20, pp.238-282, 2013. ,
Ethical challenges of the use of whole exome sequencing in the clinic, World J Pediatr Congenit Heart Surg, vol.4, pp.58-61, 2013. ,
A timely arrival for genomic medicine, Genet Med, vol.13, pp.195-201, 2011. ,
Novel ?-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study, Circ Cardiovasc Genet, vol.7, pp.741-50, 2014. ,
Wholeexome sequencing improves mutation detection in a diagnostic epidermolysis bullosa laboratory, Br J Dermatol, vol.172, pp.94-100, 2015. ,
Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound, Hum Mol Genet, vol.23, pp.3269-77, 2014. ,
Clinical application of exome sequencing in undiagnosed genetic conditions, J Med Genet, vol.49, pp.353-61, 2012. ,
Developing genome and exome sequencing for candidate gene identification in inherited disorders: An integrated technical and bioinformatics approach, Arch Pathol Lab Med, vol.137, pp.415-448, 2013. ,
Genomes in the clinic: the Gustave Roussy Cancer Center experience, Curr Opin Genet Dev, vol.24, pp.99-106, 2014. ,
Whole-exome sequencing emerges as clinical diagnostic tool: Testing method proves useful for diagnosing wide range of genetic disorders, Am J Med Genet Part A, vol.164, pp.ix-x, 2014. ,
Implementing individualized medicine into the medical practice, Am J Med Genet C: Semin Med Genet, vol.166, pp.15-23, 2014. ,
Clinical exome sequencing in daily practice: 1,000 patients and beyond, Genome Med, vol.6, issue.2, 2014. ,
Genomics in clinical practice: lessons from the front lines, Sci Transl Med, vol.5, pp.194-199, 2013. ,
Whole exome sequencing for cancer -is there evidence of clinical utility?, Adv Genomics Genet, vol.4, p.115, 2014. ,
Clinical application of amplicon-based next-generation sequencing in cancer, Cancer Genet, vol.206, pp.413-422, 2013. ,
Rare-disease genetics in the era of next-generation sequencing: discovery to translation, Nat Rev Genet, vol.14, pp.681-91, 2013. ,
Rethinking clinical practice: clinical implementation of exome sequencing, Per Med, vol.9, pp.785-792, 2012. ,
Mutational profiling in patients with MDS: ready for every-day use in the clinic?, Best Pract Res Clin Haematol, vol.28, pp.32-42, 2015. ,
Current insights into renal ciliopathies: what can genetics teach us?, Pediatr Nephrol, vol.28, pp.863-74, 2013. ,
Next generation massively parallel sequencing of targeted exomes to identify genetic mutations in primary ciliary dyskinesia: implications for application to clinical testing, Genet Med, vol.13, pp.218-247, 2011. ,
Clinical application of whole exome sequencing: not (yet) ready for primetime, Curr Opin Pediatr, vol.24, pp.663-667, 2012. ,
Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing, Genet Med, vol.17, issue.6, pp.444-51, 2015. ,
Whole genome sequencing (WGS), whole exome sequencing (WES) and clinical exome sequencing (CES) in patient care, J Lab Med, vol.38, pp.221-251, 2014. ,
AML genomics for the clinician, Semin Hematol, vol.51, pp.322-331, 2014. ,
Delivery of a clinical genomics service, Genes (Basel), vol.5, pp.1001-1018, 2014. ,
Genetic screening and diagnosis in epilepsy?, Curr Opin Neurol, vol.28, pp.136-178, 2015. ,
Sequencing your genome: what does it mean?, Methodist Debakey Cardiovasc J, vol.10, pp.3-6, 2014. ,
Genetic testing for inherited ocular disease: delivering on the promise at last?, Clin Experiment Ophthalmol, vol.42, pp.65-77, 2014. ,
Applications of high-throughput DNA sequencing to benign hematology, Blood, vol.122, pp.3575-82, 2013. ,
New clinical molecular diagnostic methods for congenital and inherited heart disease, Expert Opin Med Diagn, vol.5, pp.9-24, 2011. ,
Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities, Hear Res, vol.288, pp.67-76, 2012. ,
Exome sequencing and the genetics of intellectual disability, Clin Genet, vol.80, pp.117-143, 2011. ,
Next-generation sequencing: ready for the clinics?, Clin Genet, vol.81, pp.503-513, 2012. ,
Impact of tumor sequencing on the use of anticancer drugs, Curr Opin Oncol, vol.26, pp.347-56, 2014. ,
Clinical implications of genetic advances in Charcot-Marie-Tooth disease, Nat Rev Neurol, vol.9, pp.562-71, 2013. ,
The promise of whole-exome sequencing in medical genetics, J Hum Genet, vol.59, pp.5-15, 2014. ,
Clinical utility of genetic testing in pediatric drugresistant epilepsy: a pilot study, Epilepsy Behav, vol.37, pp.241-249, 2014. ,
Next generation sequencing (NGS) strategies for the genetic testing of myopathies, Acta Myol, vol.31, pp.196-200, 2012. ,
Defining and managing incidental findings in genetic and genomic practice, J Med Genet, vol.51, pp.715-738, 2014. ,
Return of genetic testing results in the era of whole-genome sequencing, Nat Rev Genet, vol.16, pp.553-562, 2015. ,
Identifying disease mutations in genomic medicine settings: current challenges and how to accelerate progress, Genome Med, vol.4, p.58, 2012. ,
Developmental disorders: deciphering exomes on a grand scale, Lancet, vol.385, pp.1266-1273, 2015. ,
Should patients with ocular genetic disorders have genetic testing?, Curr Opin Ophthalmol, vol.25, pp.359-65, 2014. ,
Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes, Contemp Clin Trials, vol.39, pp.1-8, 2014. ,
Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era, Crit Rev Clin Lab Sci, vol.51, pp.249-62, 2014. ,
Molecular diagnostic testing of cytology specimens: current applications and future considerations, J Am Soc Cytopathol, vol.3, pp.280-94, 2014. ,
Next generation sequencing and the future of genetic diagnosis, Neurotherapeutics, vol.11, pp.699-707, 2014. ,
Linking genes to neurological clinical practice: the genomic basis for neurorehabilitation, J Neurol Phys Ther, vol.39, pp.52-61, 2015. ,
Translating genomic discoveries to the clinic in pediatric oncology, Curr Opin Pediatr, vol.27, pp.34-43, 2015. ,
Next-generation sequencing for the diagnosis of cardiac arrhythmia syndromes, Heart Rhythm, vol.12, pp.1062-70, 2015. ,
The spectrum of axonopathies: from CMT2 to HSP, Neurology, vol.83, pp.580-581, 2014. ,
Molecular diagnostics of cardiovascular diseases in sudden unexplained death, Cardiovasc Pathol, vol.23, pp.1-4, 2014. ,
Hyperhomocysteinemia: related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues, Mol Genet Metab, vol.113, pp.27-33, 2014. ,
Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system, Neurobiol Aging, vol.35, pp.2881-2892, 2014. ,
Integrating genomics into prognostic models for AML, Semin Hematol, vol.51, pp.298-305, 2014. ,
Clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants, Hum Mutat, vol.2014, issue.35, pp.265-274, 2013. ,
Present and future molecular testing of lung carcinoma, Adv Anat Pathol, vol.21, pp.94-103, 2014. ,
New genetic testing in prenatal diagnosis, Semin Fetal Neonatal Med, vol.19, pp.214-223, 2014. ,
Can we afford to sequence every newborn baby's genome?, Hum Mutat, vol.36, pp.283-289, 2015. ,
Challenges in evaluating next-generation sequence data for clinical decisions, Nurs Outlook, vol.63, pp.48-50, 2015. ,
Genome-scale sequencing in clinical care: establishing molecular diagnoses and measuring value, JAMA, vol.312, pp.1865-1872, 2014. ,
Practical considerations in the clinical application of whole-exome sequencing, Clin Genet, vol.89, issue.2, pp.173-81, 2016. ,
Clinical whole-exome sequencing: are we there yet, Genet Med, vol.16, pp.717-726, 2014. ,
Translating next generation sequencing to practice: opportunities and necessary steps, Mol Oncol, vol.7, pp.743-55, 2013. ,
Guidelines for diagnostic next-generation sequencing, Eur J Hum Genet, vol.24, pp.2-5, 2016. ,
Committee; on behalf of the ACMG Laboratory Quality Assurance. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, vol.17, pp.405-428, 2015. ,
Genomic sequencing procedure microcosting analysis and health economic cost-impact analysis: a report of the association for molecular pathology, J Mol Diagnostics, vol.18, pp.319-347, 2016. ,
Performance of ACMG/AMP variant interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research (CSER) consortium, Am J Hum Genet, 2016. ,
Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics, Genet Med, vol.17, pp.505-512, 2015. ,
Diagnostic odyssey in severe neurodevelopmental disorders: Towards clinical whole-exome sequencing as a first-line diagnostic test, Clin Genet, vol.89, issue.6, pp.700-707, 2016. ,
Next-generation sequencing-based genome diagnostics across clinical genetics centers: implementation choices and their effects, Eur J Hum Genet, vol.23, issue.9, pp.1142-50, 2015. ,